Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone49-21-4-30-1
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$46.75 billion
Profitability
Miscellaneous
Employees99,820
Next Earnings Date5/2/2019 (Estimated)
OptionableNot Optionable
Bayer (OTCMKTS:BAYRY) Frequently Asked Questions
What is Bayer's stock symbol?
Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."
How were Bayer's earnings last quarter?
Bayer AG (OTCMKTS:BAYRY) announced its quarterly earnings results on Wednesday, February, 27th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.05. The company had revenue of $12.62 billion for the quarter. Bayer had a return on equity of 12.39% and a net margin of 4.74%. View Bayer's Earnings History.
When is Bayer's next earnings date?
What is the consensus analysts' recommendation for Bayer?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bayer.
Has Bayer been receiving favorable news coverage?
Headlines about BAYRY stock have trended somewhat negative on Wednesday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bayer earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the near future.
Who are some of Bayer's key competitors?
Some companies that are related to Bayer include Pfizer (PFE), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Novo Nordisk A/S (NVO), AbbVie (ABBV), Sanofi (SNY), GlaxoSmithKline (GSK), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Celgene (CELG), Shire (SHPG) and Zoetis (ZTS).
What other stocks do shareholders of Bayer own?
Who are Bayer's key executives?
Bayer's management team includes the folowing people:
- Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
- Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
- Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
- Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
- Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)
How do I buy shares of Bayer?
Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bayer's stock price today?
One share of BAYRY stock can currently be purchased for approximately $17.3650.
How big of a company is Bayer?
Bayer has a market capitalization of $64.77 billion and generates $46.75 billion in revenue each year. The company earns $2.00 billion in net income (profit) each year or $1.75 on an earnings per share basis. Bayer employs 99,820 workers across the globe.
What is Bayer's official website?
How can I contact Bayer?
Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]
MarketBeat Community Rating for Bayer (OTCMKTS BAYRY)
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
